Recent studies on biotherapeutic protein production have shown perfusion processes as a superior technology vs. the traditional batch and fed batch approaches. Due to its associated process stability and reducing effect of varying conditions inside the bioreactor, Perfusion can deliver lower production costs and higher titer, especially in the case of low titer or fragile […]